BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16111845)

  • 1. Preparation and characterization of novel fast disintegrating capsules (Fastcaps) for administration in the oral cavity.
    Ciper M; Bodmeier R
    Int J Pharm; 2005 Oct; 303(1-2):62-71. PubMed ID: 16111845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified conventional hard gelatin capsules as fast disintegrating dosage form in the oral cavity.
    Ciper M; Bodmeier R
    Eur J Pharm Biopharm; 2006 Feb; 62(2):178-84. PubMed ID: 16260126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing gelatin-starch blends for use as capsule materials.
    Zhang N; Liu H; Yu L; Liu X; Zhang L; Chen L; Shanks R
    Carbohydr Polym; 2013 Jan; 92(1):455-61. PubMed ID: 23218320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
    Cole ET; Cadé D; Benameur H
    Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheology and filling characteristics of particulate dispersions in polymer melt formulations for liquid fill hard gelatin capsules.
    Rowley G; Hawley AR; Dobson CL; Chatham S
    Drug Dev Ind Pharm; 1998 Jul; 24(7):605-11. PubMed ID: 9876504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A scintigraphic investigation of the disintegration behaviour of capsules in fasting subjects: a comparison of hypromellose capsules containing carrageenan as a gelling agent and standard gelatin capsules.
    Tuleu C; Khela MK; Evans DF; Jones BE; Nagata S; Basit AW
    Eur J Pharm Sci; 2007 Mar; 30(3-4):251-5. PubMed ID: 17188473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A review on liquid-filled hard gelatin capsules].
    Ma JH; Yang M; Zeng M; Chen XM; Lan J
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):602-5. PubMed ID: 18536390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of texture analysis to study hydrophilic solvent effects on the mechanical properties of hard gelatin capsules.
    Mei X; Etzler FM; Wang Z
    Int J Pharm; 2006 Nov; 324(2):128-35. PubMed ID: 16844327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects.
    Wang CY; Ho HO; Lin LH; Lin YK; Sheu MT
    Int J Pharm; 2005 Jun; 297(1-2):89-97. PubMed ID: 15885936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
    Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K
    Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing hydroxypropyl methylcellulose/hydroxypropyl starch blends for use as capsule materials.
    Zhang L; Wang Y; Liu H; Yu L; Liu X; Chen L; Zhang N
    Carbohydr Polym; 2013 Oct; 98(1):73-9. PubMed ID: 23987318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice.
    Wang GM; Chen CH; Ho HO; Wang SS; Sheu MT
    Int J Pharm; 2006 Aug; 319(1-2):71-81. PubMed ID: 16701971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets.
    Chandrasekhar R; Hassan Z; Alhusban F; Smith AM; Mohammed AR
    Eur J Pharm Biopharm; 2009 May; 72(1):119-29. PubMed ID: 19073253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of rheological behaviour of particulate/polymer dispersions on liquid-filling characteristics for hard gelatin capsules.
    Kattige A; Rowley G
    Int J Pharm; 2006 Jun; 316(1-2):74-85. PubMed ID: 16567071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation of multiparticulate systems as lyophilised orally disintegrating tablets.
    Alhusban F; Perrie Y; Mohammed AR
    Eur J Pharm Biopharm; 2011 Nov; 79(3):627-34. PubMed ID: 21693189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of glycine/citric acid on the dissolution stability of hard gelatin capsules.
    Adesunloye TA; Stach PE
    Drug Dev Ind Pharm; 1998 Jun; 24(6):493-500. PubMed ID: 9876614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of gelling granules to improve oral administration.
    Ito I; Ito A; Unezaki S
    Drug Discov Ther; 2015 Jun; 9(3):213-20. PubMed ID: 26193944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
    Cirri M; Mura P; Mora PC
    Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soft, chewable gelatin-based pharmaceutical oral formulations: a technical approach.
    Dille MJ; Hattrem MN; Draget KI
    Pharm Dev Technol; 2018 Jun; 23(5):504-511. PubMed ID: 28532266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus.
    Garbacz G; Cadé D; Benameur H; Weitschies W
    Eur J Pharm Sci; 2014 Jun; 57():264-72. PubMed ID: 24021609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.